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Tuning Molecular Recognition of RNA and 
DNA via Sugar Modification
Christian J. Leumann*
Abstract: This minireview highlights three aspects of our recent work in the area of sugar modified oligonucleotide 
analogues. It provides an overview over recent results on the conformationally constrained analogue tricyclo-DNA 
with special emphasis of its antisense properties, it summarizes results on triple-helix forming oligodeoxynucle-
otides containing pyrrolidino-nucleosides with respect to DNA recognition via the dual recognition mode, and it 
highlights the advantageous application of the orthogonal oligonucleotidic pairing system homo-DNA in molecular 
beacons for DNA diagnostics.
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ar, the phosphate and the nucleobase, are 
equally amenable to chemical modification 
to improve on desired properties. Modifica-
tions at the sugar unit, ranging from simple 
substitutions at the 2ʹ-hydroxyl group to 
complete replacement of the sugar by dif-
ferent structural scaffolds have the most 
profound effect on the pairing properties 
of derived oligonucleotides. For example, 
changing the geometry of some of the tor-
sion angles in the backbone, as for example 
in the case of homo-DNA, bc-DNA or xylo-
DNA leads to base association preferences 
different from that of the Watson-Crick 
type, or to orthogonal base-pairing systems. 
On the other side, conformational constric-
tion or preorganization of backbone torsion 
angles in the sugar unit as in the case of 
LNA or tricyclo-DNA (tc-DNA) leads to 
increased complex stability by maintain-
ing the typical Watson-Crick association 
mode. Therefore understanding the relation 
between sugar structure and pairing proper-
ties in sufficient detail is the key for tuning 
oligonucleotide properties at will by chemi-
cal modification.
In the following we concentrate on three 
different sugar modifications that we have 
recently investigated in three different con-
texts. First we summarize recent results 
with conformationally constrained oligonu-
cleotides showing increased RNA affinity, 
then we focus on a combination of specific 
base and unspecific phosphate recognition 
as a means to increase triple-helix stability, 
and in the last section we give an example 
on how orthogonal oligonucleotidic base-
pairing systems that do not cross-pair with 
natural nucleic acids, can advantageously 
be used in biotechnology.
Conformationally Constrained 
Oligonucleotides for RNA 
Recognition
Over the last years we developed the 
DNA analogue tricyclo-(tc)DNA (Fig. 1). 
As LNA, tc-DNA belongs to the class of 
conformationally constrained oligonucle-
otide analogues. These were specifically 
designed to increase complementary RNA 
or DNA affinity by reducing the entropy 
change upon duplex formation via structur-
al preorganization of the single strand. We 
reported in the past on the synthesis and du-
plex formation properties of tricyclo-DNA 
and found indeed reduced entropy changes 
upon duplex formation and increased ther-
mostability of duplexes with RNA by 2–4 
°C in melting temperature per modification 
relative to DNA [2][3]. With this it is one 
of the strongest RNA-binders. Structurally 
tc-DNA was found to be an RNA mimic as 
deduced from CD-spectroscopic and mod-
eling experiments. Furthermore, tc-DNA is 
very stable against 3ʹ-phosphodiesterases 
(snake venom phosphodiesterase) and is 
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Introduction
Oligonucleotides have found widespread 
interest and application in DNA and RNA 
diagnostics, as tools in molecular biology 
and as antisense agents and gene silencers 
in functional genomics and human therapy. 
For many of these applications, however, 
unmodified oligonucleotides are of limited 
use due to their insufficient biostability, 
bioavailability and due to the fact that their 
affinity to complementary DNA and RNA 
is in many instances not sufficient to gen-
erate a biological response. Some of these 
drawbacks can be overcome by chemical 
modification of oligonucleotides [1]. All of 
the three components of the repetitive struc-
tural unit of DNA or RNA, namely the sug-
Fig. 1. Chemical structures of tricyclo-DNA and 
LNA
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
53
10
7 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
MODIFIED OLIGONUCLEOTIDES 777
CHIMIA 2005, 59, No. 11
also stable in sera and cell extracts. In addi-
tion we found that tcDNA/RNA hybrid du-
plexes do not elicit RNase H activity. These 
properties clearly prompted us to perform 
nuclear antisense experiments on two dif-
ferent targets. During these experiments we 
also compared the properties of tc-DNA to 
those of commercially available and widely 
used 2ʹ-OMe-RNA and locked nucleic acid 
(LNA).
We tested for antisense effects in HeLa 
cell lines stably expressing the human β-
globin gene with two different point muta-
tions in the second intron. These mutations 
lead to the inclusion of an aberrant exon in 
β-globin mRNA. Lipofectamine-mediated 
delivery of a 17-mer tricyclo-oligodeoxy-
nucleotide complementary to the cryptic 
3ʹ splice site at the beginning of the aber-
rant exon results in correction of splicing 
already at nM concentrations with up to 
100-fold enhanced efficiency relative to a 
2ʹ-OMe-PS-RNA oligonucleotide of the 
same length and sequence. In contrast to 
2ʹ-OMe-PS-RNA, tricyclo-DNA shows 
antisense activity even in the absence of 
lipofectamine, albeit only at much higher 
oligonucleotide concentrations [4].
In another setup the nuclear antisense 
properties of a series of tricyclo(tc)-DNA 
oligonucleotide 9–15mers, targeted against 
the 3ʹ and 5ʹ splice sites of exon 4 of cy-
clophilin A (CyPA) pre-mRNA, were 
evaluated in HeLa cells and compared with 
those of corresponding LNA-oligonucle-
otides [5]. While the 9mers showed no 
significant antisense effect, the 11–15mers 
induced single and double exon skipping to 
about an equal extent upon lipofectamine 
mediated transfection in a sequence and 
dose dependent manner, as revealed by a 
RT-PCR assay. The antisense efficacy of the 
tc-oligonucleotides was found to be supe-
rior to that of the LNA-oligonucleotides in 
all cases by a factor of at least 4–5. A tc-oli-
gonucleotide 15mer completely abolished 
CyPA mRNA production at 0.2 μM concen-
tration. The antisense effect was confirmed 
by western blot analysis which revealed a 
reduction of CyPA protein to 13% of its 
normal level. Fluorescence microscopic 
investigations with a fluorescein labeled 
tc-15mer revealed a strong propensity for 
homogeneous nuclear localization of this 
backbone type after lipofectamine mediated 
transfection, while the corresponding LNA 
15mer showed a less clear cellular distri-
bution pattern. Transfection without lipid 
carrier showed no significant internaliza-
tion of both tc- and LNA-oligonucleotides. 
The comparison of LNA with tcDNA in the 
latter experiment surprisingly revealed that 
there is no linear correlation between RNA 
affinity and antisense efficacy in this case, 
indicating that other factors such as intra-
cellular distribution may critically deter-
mine the efficacy of oligonucleotides. The 
current state of evaluation of tcDNA clearly 
shows that it is an excellent candidate for 
nuclear antisense applications. 
RNase H activity leading to the degra-
dation of the RNA is an important antisense 
mechanism that increases the efficacy of 
antisense oligonucleotides when targeted 
to mature mRNAs. A way out of the di-
lemma that many chemically modified oli-
gonucleotide analogues, including tcDNA, 
are unable to activate RNase H consists in 
the use of so-called ‘gapmers’, chimaeric 
oligonucleotides in which both ends consist 
of chemically modified units while the cen-
ter of the sequence contains 6–10 unmodi-
fied DNA-residues (RNase H window). 
We therefore decided to explore whether 
the gapmer concept can also be applied 
to tc-DNA [6]. A 18mer tc-DNA gapmer 
containing a DNA window of eight nucleo-
tides in the center, flanked by five tc-DNA 
residues each on the 5ʹ- and the 3ʹ-side was 
found to be as competent as normal DNA 
in eliciting RNase H activity. This gapmer 
was also largely resistant to biodegradation 
in both human and fetal calf serum. Thus 
all the advantages of the gapmer strategy 
originally developed for 2ʹ-O-alkyl RNA 
also apply to the tc-DNA scaffold.
Concomittant Base and Phosphate 
Recognition for Improving DNA 
Triple Helix Stability
Sequence specific binding of triplex 
forming oligonucleotides (TFOs) in the 
major groove of double stranded DNA can 
control and modulate gene expression at the 
level of transcription and is the basis of an-
tigene technology [7]. TFOs can bind to ho-
mopurine/homopyrimidine tracts of DNA 
in either parallel or antiparallel alignment 
relative to the purine target strand, forming 
Hoogsteen or reversed-Hoogsteen base-
triples. Unfortunately, the use of TFOs as 
antigene agents suffers from several limita-
tions. Low thermal stability of the triplexes, 
low biostability of the TFOs in vivo, low 
bioavailability, sequence restrictions to ho-
mopurine/homopyrimidine DNA tracts and 
a strong pH dependence in the parallel bind-
ing motif due to C+•G-C triplet formation 
are among the major obstacles that reduce 
the efficacy of antigene agents and that slow 
down the development and applications of 
antigene technology. Many strategies have 
been exploited to avoid these drawbacks, 
including the use of conformationally re-
stricted DNA analogues to increase thermal 
stability [8], or the design of new selective 
nucleobase analogues to alleviate target se-
quence restriction [9][10].
As part of our current research we are 
interested in increasing TFO affinity to a 
DNA target by applying the ‘dual recog-
nition’ approach, originally developed by 
Cuenoud and coworkers [11]. In this ap-
proach, a target dsDNA is not only recog-
nized by selective base–base interactions 
but also via an additional, non-specific salt 
bridge between an appropriately placed 
positive charge in the TFO and a negatively 
charged phosphate oxygen in the target 
DNA backbone [11][12].
Based on recent X-ray data on a paral-
lel DNA triplex [13], molecular modeling 
showed that replacement of the 4ʹ-oxygen 
in a deoxynucleoside residue of a TFO by 
a basic nitrogen would potentially place a 
positive charge next to a non-bridging pro-
R-phosphate oxygen of the purine strand 
of a target dsDNA (Fig. 2). We therefore 
prepared the corresponding pyrrolidino-
pseudonucleosides and incorporated them 
into oligonucleotides. TFOs containing pyr-
rolidino pseudoisocytidine units (dpψiC-se-
ries) exhibit a significant increase in triplex 
stability compared to unmodified TFOs 
in at least two different sequence contexts 
[14]. By comparison with TFOs containing 
ribo-pseudo-isoC units (drψiC-series) it 
clearly emerges that the increase in stabil-
ity is associated with the protonation of the 
pyrrolidino ring nitrogen which confirms 
the presence of attractive electrostatic in-
teractions between the additional positive 
charge in the TFOs and the phosphodiester 
backbone of the target duplex. A somewhat 
puzzling situation remains in that this ad-
ditional electrostatic stabilization seems to 
be restricted to dpψiC units and does not 
occur with dpψU units for a yet unknown 
reason.
Orthogonal Base-pairing Systems 
for Applications in DNA Diagnostics
The post-genomic era continuously 
demands novel and improved DNA recog-
nition probes with high sensitivity and se-
lectivity for use in fundamental biomedical 
studies, disease diagnosis, functional ge-
nomics and drug discovery. A particularly 
useful concept for sensing single-stranded 
DNA or RNA with high mismatch dis-
crimination is that of the molecular bea-
cons (MBs), first described by Kramer and 
coworkers [15]. MBs are single-stranded 
oligonucleotide hybridization probes that 
form a stem-loop structure. The loop con-
tains a probe sequence that is designed to 
be complementary to a DNA-target, and the 
stem is formed by complementary arm se-
quences that are located on either side of the 
probe. A fluorophore is covalently linked to 
the end of one arm and a quencher to the 
end of the other arm. In the absence of a 
target the molecular beacon is closed, and 
fluorescence is quenched. However, after 
hybridization to a nucleic acid target se-
quence the stem of the molecular beacon 
melts and fluorescence is emitted due to in-
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creased distance between fluorophore and 
quencher (Fig. 3A).
MB probes display higher target se-
lectivity compared to linear probes, due to 
their structurally well-defined hairpin loop 
state in the absence of a target [16]. The MB 
concept has been developed and exploited 
extensively in the past for the detection of 
single nucleotide polymorphisms [17], for 
visualizing the distribution and transport 
of mRNAs in living cells [18], as probes 
for reporting enzymatic activity [19], as 
well as for a variety of other applications 
[20]. Although molecular beacons are very 
sensitive to mismatches in the probe-target 
region their flanking arm sequences, con-
taining 4–5 nucleotides each are prone to 
fortuitously participate in target binding, 
thus constituting a potential source of false 
positive results. A solution to this problem 
exists in theory by replacing the stem part 
of an MB by an oligonucleotidic pairing 
system that is orthogonal and consequently 
does not cross-pair with DNA or RNA.
In our approach we chose homo-DNA 
(Fig. 3B) for the stem part of MBs. Homo-
DNA, a homologue of natural DNA, was 
shown before by Eschenmoser and cowork-
ers to form stable, antiparallel duplexes with 
itself, without cross-pairing to natural DNA 
[21]. Moreover, homo-DNA can easily be 
prepared by standard automated phosphor-
amidite chemistry and is thus fully compat-
ible with DNA synthesis [22]. Particularly 
intriguing is the property of homo-DNA 
oligoadenylates to form A-A self-pairs of 
the reversed Hoogsteen type (Fig. 3C) with 
thermal stabilities that roughly match that 
of natural Watson-Crick base-pairs. Ex-
ploiting this property reduces the number 
of necessary building blocks for the arms 
of an MB to only one.
We found that hybrid MBs with a ho-
moadenylate homo-DNA stem and a DNA 
probe sequence (Fig. 3D) readily form 
hairpin-loop structures with a stability that 
roughly matches that of an unmodified MB 
[23]. No interaction between the homo-
DNA sequence tracts with the target DNA 
was observed. By targeting with the loop 
region a single sequence in a DNA array 
we could show that such hybrid homo-
DNA beacons significantly enhanced target 
selectivity compared to conventional bea-
cons. The signal to background ratios of the 
homo-DNA molecular beacons were found 
to be similar to that of the conventional 
MBs as deduced from fluorescence melt-
ing profiles of the beacons alone as well as 
with target.
The use of non-natural oligonucleotidic 
pairing systems in biotechnology is ap-
pealing and only little explored. Among 
the few examples are L-DNA that has been 
used in the past as aptamers (spiegelmers) 
for selective binding of biopolymers [24], 
pyranosyl RNA (pRNA) as a nanosystem 
Fig. 2. Top: Excerpt of the NMR structure of 2ʹ-aminoethyl-RNA in complex with double-stranded 
DNA (left) from [12] and schematic representation of the dual recognition principle (right). Bottom: 
Equivalent representations for the case of pyrrolidino-nucleosides as well as chemical structures of 
the prepared pyrrolidino-nucleosides.
Fig. 3. A: Working principle of the molecular beacon technology; B: Chemical structure of homo-DNA; 
C: Reversed Hoogsteen A-A base-pairing as found in homo-DNA homoadenylates; D: Schematic 
representation of homo-DNA/DNA hybrid molecular beacons
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[25], and the 3ʹ-deoxy variant of pRNA 
(pDNA) as a scaffold for tuning aptamer 
and ribozyme activity [26]. The molecular 
beacon approach described above is the 
first application of homo-DNA in nucleic 
acid biotechnology.
Conclusions
Oligonucleotide chemistry has already 
provided many tools for molecular biology 
and has been instrumental for the success of 
functional genomics. As many other fields 
in science, also DNA chemistry has experi-
enced various cycles of low and high tides 
since the development of solid phase DNA 
synthesis. Waves of interest were first as-
sociated with site-directed mutagenesis and 
PCR, then with antisense research as well 
as selection/amplification protocols for the 
generation of ribozymes and aptamers, and 
most recently with small interfering RNAs 
and micro RNAs. Although many aspects 
of the chemistry of this molecule have al-
ready been explored, there is still plenty of 
room for developing novel and improved 
tools to meet tomorrow’s needs in DNA 
diagnosis and in oligonucleotide dependent 
therapies.
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